Continuous muscle, glial, epithelial, neuronal, and hemocyte cell lines for Drosophila research

  1. Nikki Coleman-Gosser
  2. Yanhui Hu
  3. Shiva Raghuvanshi
  4. Shane Stitzinger
  5. Weihang Chen
  6. Arthur Luhur
  7. Daniel Mariyappa
  8. Molly Josifov
  9. Andrew Zelhof
  10. Stephanie E Mohr
  11. Norbert Perrimon  Is a corresponding author
  12. Amanda Simcox  Is a corresponding author
  1. The Ohio State University, United States
  2. Harvard Medical School, United States
  3. Indiana University, United States
  4. Harvard Medical School, Howard Hughes Medical Institute, United States

Abstract

Expression of activated Ras, RasV12, provides Drosophila cultured cells with a proliferation and survival advantage that simplifies the generation of continuous cell lines. Here we used lineage restricted RasV12 expression to generate continuous cell lines of muscle, glial, and epithelial cell type. Additionally, cell lines with neuronal and hemocyte characteristics were isolated by cloning from cell cultures established with broad RasV12 expression. Differentiation with the hormone ecdysone caused maturation of cells from mesoderm lines into active muscle tissue and enhanced dendritic features in neuronal-like lines. Transcriptome analysis showed expression of key cell-type specific genes and the expected alignment with single cell sequencing and in situ data. Overall, the technique has produced in vitro cell models with characteristics of glia, epithelium, muscle, nerve, and hemocyte. The cells and associated data are available from the Drosophila Genomic Resource Center.

Data availability

Sequencing data have been deposited in GEO under accession code GSE219105.

The following data sets were generated

Article and author information

Author details

  1. Nikki Coleman-Gosser

    Department of Molecular Genetics, The Ohio State University, Columbus, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Yanhui Hu

    Department of Genetics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Shiva Raghuvanshi

    Department of Molecular Genetics, The Ohio State University, Columbus, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Shane Stitzinger

    Department of Molecular Genetics, The Ohio State University, Columbus, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Weihang Chen

    Department of Genetics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Arthur Luhur

    Department of Biology, Indiana University, Bloomington, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Daniel Mariyappa

    Department of Biology, Indiana University, Bloomington, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4775-1656
  8. Molly Josifov

    Department of Molecular Genetics, The Ohio State University, Columbus, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2899-7186
  9. Andrew Zelhof

    Department of Biology, Indiana University, Bloomington, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Stephanie E Mohr

    Department of Genetics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9639-7708
  11. Norbert Perrimon

    Harvard Medical School, Howard Hughes Medical Institute, Boston, United States
    For correspondence
    perrimon@genetics.med.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7542-472X
  12. Amanda Simcox

    Department of Molecular Genetics, The Ohio State University, Columbus, United States
    For correspondence
    simcox.1@osu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5572-7042

Funding

National Institutes of Health Office of the Director (R24 OD019847)

  • Stephanie E Mohr
  • Norbert Perrimon
  • Amanda Simcox

National Institutes of Health (P40OD010949)

  • Andrew Zelhof

National Institutes of Health (P41 GM132087)

  • Andrew Zelhof

National Science Foundation (IOS 1419535)

  • Amanda Simcox

Howard Hughes Medical Institute

  • Norbert Perrimon

Women & Philanthropy at the Ohio State University (Grant)

  • Amanda Simcox

National Science Foundation (Support while serving at the National Science Foundation)

  • Amanda Simcox

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,287
    views
  • 379
    downloads
  • 1
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nikki Coleman-Gosser
  2. Yanhui Hu
  3. Shiva Raghuvanshi
  4. Shane Stitzinger
  5. Weihang Chen
  6. Arthur Luhur
  7. Daniel Mariyappa
  8. Molly Josifov
  9. Andrew Zelhof
  10. Stephanie E Mohr
  11. Norbert Perrimon
  12. Amanda Simcox
(2023)
Continuous muscle, glial, epithelial, neuronal, and hemocyte cell lines for Drosophila research
eLife 12:e85814.
https://doi.org/10.7554/eLife.85814

Share this article

https://doi.org/10.7554/eLife.85814

Further reading

    1. Cell Biology
    Chengfang Pan, Ying Liu ... Changlong Hu
    Research Article

    Prostaglandin E2 (PGE2) is an endogenous inhibitor of glucose-stimulated insulin secretion (GSIS) and plays an important role in pancreatic β-cell dysfunction in type 2 diabetes mellitus (T2DM). This study aimed to explore the underlying mechanism by which PGE2 inhibits GSIS. Our results showed that PGE2 inhibited Kv2.2 channels via increasing PKA activity in HEK293T cells overexpressed with Kv2.2 channels. Point mutation analysis demonstrated that S448 residue was responsible for the PKA-dependent modulation of Kv2.2. Furthermore, the inhibitory effect of PGE2 on Kv2.2 was blocked by EP2/4 receptor antagonists, while mimicked by EP2/4 receptor agonists. The immune fluorescence results showed that EP1–4 receptors are expressed in both mouse and human β-cells. In INS-1(832/13) β-cells, PGE2 inhibited voltage-gated potassium currents and electrical activity through EP2/4 receptors and Kv2.2 channels. Knockdown of Kcnb2 reduced the action potential firing frequency and alleviated the inhibition of PGE2 on GSIS in INS-1(832/13) β-cells. PGE2 impaired glucose tolerance in wild-type mice but did not alter glucose tolerance in Kcnb2 knockout mice. Knockout of Kcnb2 reduced electrical activity, GSIS and abrogated the inhibition of PGE2 on GSIS in mouse islets. In conclusion, we have demonstrated that PGE2 inhibits GSIS in pancreatic β-cells through the EP2/4-Kv2.2 signaling pathway. The findings highlight the significant role of Kv2.2 channels in the regulation of β-cell repetitive firing and insulin secretion, and contribute to the understanding of the molecular basis of β-cell dysfunction in diabetes.

    1. Cell Biology
    Weihua Wang, Junqiao Xing ... Zhangfeng Hu
    Research Article

    Existence of cilia in the last eukaryotic common ancestor raises a fundamental question in biology: how the transcriptional regulation of ciliogenesis has evolved? One conceptual answer to this question is by an ancient transcription factor regulating ciliary gene expression in both uni- and multicellular organisms, but examples of such transcription factors in eukaryotes are lacking. Previously, we showed that an ancient transcription factor X chromosome-associated protein 5 (Xap5) is required for flagellar assembly in Chlamydomonas. Here, we show that Xap5 and Xap5-like (Xap5l) are two conserved pairs of antagonistic transcription regulators that control ciliary transcriptional programs during spermatogenesis. Male mice lacking either Xap5 or Xap5l display infertility, as a result of meiotic prophase arrest and sperm flagella malformation, respectively. Mechanistically, Xap5 positively regulates the ciliary gene expression by activating the key regulators including Foxj1 and Rfx families during the early stage of spermatogenesis. In contrast, Xap5l negatively regulates the expression of ciliary genes via repressing these ciliary transcription factors during the spermiogenesis stage. Our results provide new insights into the mechanisms by which temporal and spatial transcription regulators are coordinated to control ciliary transcriptional programs during spermatogenesis.